DB18312InvestigationalProtein Based Therapies
Telitacicept: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Tumor necrosis factor ligand superfamily member 13B and Tumor necrosis factor ligand superfamily member 13
- Also known as
- (L120>A,L121>E,G123>A,A216>S,P217>S)-TACI (TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF13B) HUMAN EXTRACELLULAR DOMAIN FRAGMENT (13-118)-PEPTIDE (1-106) FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G1 · 13-118-tumor necrosis factor receptor superfamily protein tnfrsf13b (human extracellular domain fragment) fusion protein with immunoglobulin g1, (human rc18 fc fragment), dimer
- Code names
- RC18-L
Resolves to
Compound
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with Telitacicept, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account